Earlier, we reported strong evidence suggesting that RUNX3 is a bladder cancer tumor suppressor gene and that it is frequently inactivated by hypermethylation of the promoter region (Kim et al. 2005). This evidence concerns the gene RUNX3 and urinary bladder carcinoma.